Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors May 24, 2022
Kymera Therapeutics presents data on the IRAK4 degrader KT-474 in different cell subsets May 24, 2022